Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease
about
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesChanging the Paradigm - Treating the Basic Defect in Cystic Fibrosis.New and Emerging Treatments for Cystic Fibrosis.Cystic fibrosis: current therapeutic targets and future approaches.Strategies in early clinical development for the treatment of basic defects of cystic fibrosis.Strategies for the etiological therapy of cystic fibrosis.
P2860
Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacokinetics and tolerabil ...... h cystic fibrosis lung disease
@ast
Pharmacokinetics and tolerabil ...... h cystic fibrosis lung disease
@en
type
label
Pharmacokinetics and tolerabil ...... h cystic fibrosis lung disease
@ast
Pharmacokinetics and tolerabil ...... h cystic fibrosis lung disease
@en
prefLabel
Pharmacokinetics and tolerabil ...... h cystic fibrosis lung disease
@ast
Pharmacokinetics and tolerabil ...... h cystic fibrosis lung disease
@en
P2093
P2860
P1476
Pharmacokinetics and tolerabil ...... h cystic fibrosis lung disease
@en
P2093
C St Clair
D Curran-Everett
D P Nichols
F J Accurso
G M Solomon
J L Taylor-Cousar
L A Felton
P2860
P304
P356
10.1016/J.JCF.2014.10.006
P577
2014-11-13T00:00:00Z